Viewray (VRAY) Receives a Buy from BTIG

In a report released yesterday, Marie Thibault from BTIG reiterated a Buy rating on Viewray (VRAYResearch Report), with a price target of $8.00. The company’s shares closed last Tuesday at $3.00, close to its 52-week low of $2.39.

According to, Thibault is a 4-star analyst with an average return of 8.1% and a 34.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Irhythm Technologies, and Edwards Lifesciences.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Viewray with a $6.00 average price target, a 104.8% upside from current levels. In a report released yesterday, Piper Sandler also maintained a Buy rating on the stock with a $6.00 price target.

See the top stocks recommended by analysts >>

Based on Viewray’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $18.88 million and GAAP net loss of $25.77 million. In comparison, last year the company earned revenue of $15.53 million and had a GAAP net loss of $26.74 million.

Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VRAY in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.

Read More on VRAY:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More